What is the recommended treatment for urinary tract infection?

Treatment of Urinary Tract Infections

For uncomplicated cystitis in women, nitrofurantoin (100 mg twice daily for 5 days) is the preferred first-line treatment, with fosfomycin (3 g single dose) and pivmecillinam (400 mg three times daily for 3-5 days) as equally appropriate alternatives. 1

Uncomplicated Cystitis in Women

First-Line Agents

The 2024 European Association of Urology guidelines prioritize three antibiotics based on their efficacy, low resistance rates, and minimal collateral damage 1:

• Nitrofurantoin: 100 mg twice daily for 5 days (monohydrate/macrocrystals or prolonged release formulations) 1
• Fosfomycin trometamol: 3 g single dose 1
• Pivmecillinam: 400 mg three times daily for 3-5 days 1

Alternative Agents

Use these only when first-line agents are contraindicated or local E. coli resistance is <20% 1:

• Trimethoprim-sulfamethoxazole (TMP/SMX): 160/800 mg twice daily for 3 days (avoid in first and last trimesters of pregnancy) 1
• Cephalosporins (e.g., cefadroxil): 500 mg twice daily for 3 days 1
• Fluoroquinolones: 3-day course, but reserve for more invasive infections due to collateral damage concerns 1

Important Caveats

• Fluoroquinolones should NOT be first-line despite their efficacy, as they should be reserved for pyelonephritis and complicated infections 1
• β-lactams are less effective as empirical first-line therapy compared to the preferred agents 2
• For mild-to-moderate symptoms, symptomatic therapy with ibuprofen may be considered as an alternative to antibiotics after shared decision-making 1

Uncomplicated Cystitis in Men

Men require longer treatment duration 1:

• TMP/SMX: 160/800 mg twice daily for 7 days 1
• Fluoroquinolones can be prescribed based on local susceptibility testing 1

The 7-day duration accounts for potential prostatic involvement that cannot be clinically excluded 1

Acute Uncomplicated Pyelonephritis

Outpatient Oral Therapy

For patients who can be managed as outpatients 1:

• Ciprofloxacin: 500-750 mg twice daily for 7 days (only if local resistance <10%) 1
• Levofloxacin: 750 mg once daily for 5 days 1
• TMP/SMX: 160/800 mg twice daily for 14 days 1
• Oral cephalosporins (cefpodoxime 200 mg twice daily or ceftibuten 400 mg once daily for 10 days) require an initial IV dose of long-acting parenteral antimicrobial like ceftriaxone 1

Critical point: Nitrofurantoin, fosfomycin, and pivmecillinam should be avoided for pyelonephritis due to insufficient efficacy data 1

Inpatient IV Therapy

For hospitalized patients requiring IV treatment 1:

• Ceftriaxone: 1-2 g once daily (recommended empirical choice for most patients) 1
• Fluoroquinolones: Ciprofloxacin 400 mg twice daily or levofloxacin 750 mg once daily 1
• Aminoglycosides: Gentamicin 5 mg/kg once daily or amikacin 15 mg/kg once daily 1
• Piperacillin-tazobactam: 2.5-4.5 g three times daily 1

Reserve carbapenems and novel broad-spectrum agents (ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam) only for patients with early culture results showing multidrug-resistant organisms 1

Duration for Pyelonephritis

• β-lactams: 7 days 1
• Fluoroquinolones: 5-7 days 1

Complicated UTIs

For complicated UTIs with systemic symptoms, use combination therapy with amoxicillin plus an aminoglycoside, a second-generation cephalosporin plus an aminoglycoside, or an IV third-generation cephalosporin. 1

Key Principles

• Treat for 7-14 days (14 days for men when prostatitis cannot be excluded) 1
• Always obtain urine culture and susceptibility testing before initiating therapy 1
• Address underlying urological abnormalities—this is mandatory for cure 1
• Ciprofloxacin should only be used if local resistance <10% AND the patient has not used fluoroquinolones in the last 6 months 1

When to Suspect Complicated UTI

Complicated UTIs occur with 1:

• Urinary tract obstruction at any site
• Foreign body (catheter, stent)
• Male sex
• Pregnancy
• Diabetes mellitus
• Immunosuppression
• Recent instrumentation
• Healthcare-associated infections
• ESBL-producing or multidrug-resistant organisms

Catheter-Associated UTIs

Only treat catheter-associated UTI when systemic symptoms are present (fever, rigors, altered mental status, flank pain, costovertebral angle tenderness) 1

• Asymptomatic bacteriuria is nearly universal with chronic catheters and should NOT be treated 1
• A negative urinalysis has excellent negative predictive value and can rule out CAUTI 1
• A positive urinalysis has very low specificity in catheterized patients and does not confirm CAUTI 1

Diagnostic Considerations

When to Obtain Urine Culture

Urine culture is recommended for 1:

• Suspected acute pyelonephritis
• Symptoms not resolving or recurring within 2-4 weeks after treatment
• Atypical symptoms
• Pregnant women
• All cases of pyelonephritis

When Culture is NOT Needed

For women with typical uncomplicated cystitis symptoms (dysuria, frequency, urgency without vaginal discharge), diagnosis can be made clinically without culture 1

Treatment Failures

If symptoms do not resolve by end of treatment or recur within 2 weeks 1:

• Obtain urine culture and susceptibility testing
• Assume the organism is not susceptible to the original agent
• Retreat with a 7-day regimen using a different antimicrobial class 1

Critical Pitfalls to Avoid

1. Do not use fluoroquinolones as first-line for uncomplicated cystitis—reserve them for pyelonephritis and complicated infections to minimize resistance and collateral damage 1

2. Do not treat asymptomatic bacteriuria except in pregnant women and before urological procedures breaching the mucosa 1

3. Do not use nitrofurantoin, fosfomycin, or pivmecillinam for pyelonephritis—they lack adequate tissue penetration 1

4. Do not use antipseudomonal agents empirically unless risk factors for nosocomial pathogens are present 1

5. Do not perform routine post-treatment cultures in asymptomatic patients 1